-
1
-
-
0037421590
-
Pharmacogenomics--drug disposition, drug targets, and side effects
-
Evans, W.E.; McLeod, H.L. Pharmacogenomics--drug disposition, drug targets, and side effects. N. Engl. J. Med., 2003, 348(6), 538-549.
-
(2003)
N. Engl. J. Med
, vol.348
, Issue.6
, pp. 538-549
-
-
Evans, W.E.1
McLeod, H.L.2
-
2
-
-
25144480988
-
Genetic susceptibility to iatrogenic malignancy
-
Allan, J.M.; Rabkin, C.S. Genetic susceptibility to iatrogenic malignancy. Pharmacogenomics, 2005, 6(6), 615-28.
-
(2005)
Pharmacogenomics
, vol.6
, Issue.6
, pp. 615-628
-
-
Allan, J.M.1
Rabkin, C.S.2
-
3
-
-
3342953639
-
Simple and complex genetics of colorectal cancer susceptibility
-
Baglioni, S.; Genuardi, M. Simple and complex genetics of colorectal cancer susceptibility. Am. J. Med. Genet. C. Semin. Med. Genet., 2004, 129C (1), 35-43.
-
(2004)
Am. J. Med. Genet. C. Semin. Med. Genet
, vol.129 C
, Issue.1
, pp. 35-43
-
-
Baglioni, S.1
Genuardi, M.2
-
4
-
-
34548252915
-
DNA base excision repair as a biomarker in molecular epidemiology studies
-
Collins, A.R.; Gaivao, I. DNA base excision repair as a biomarker in molecular epidemiology studies. Mol. Aspects Med., 2007, 28(3-4), 307-322.
-
(2007)
Mol. Aspects Med
, vol.28
, Issue.3-4
, pp. 307-322
-
-
Collins, A.R.1
Gaivao, I.2
-
5
-
-
22244477048
-
XRCC1 polymorphisms and cancer risk: A meta-analysis of 38 case-control studies
-
Hu, Z.; Ma, H.; Chen, F.; Wei, Q.; Shen, H. XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol. Biomarkers Prev., 2005, 14 (7), 1810-1818.
-
(2005)
Cancer Epidemiol. Biomarkers Prev
, vol.14
, Issue.7
, pp. 1810-1818
-
-
Hu, Z.1
Ma, H.2
Chen, F.3
Wei, Q.4
Shen, H.5
-
6
-
-
27744531188
-
Genetic polymorphisms in the base excision repair pathway and cancer risk: A HuGE review
-
Hung, R.J.; Hall, J.; Brennan, P.; Boffetta, P. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am. J. Epidemiol., 2005, 162 (10), 925-942.
-
(2005)
Am. J. Epidemiol
, vol.162
, Issue.10
, pp. 925-942
-
-
Hung, R.J.1
Hall, J.2
Brennan, P.3
Boffetta, P.4
-
7
-
-
33750311904
-
Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: A meta-analysis
-
Kiyohara, C.; Takayama, K.; Nakanishi, Y. Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis. Lung Cancer, 2006, 54(3), 267-283.
-
(2006)
Lung Cancer
, vol.54
, Issue.3
, pp. 267-283
-
-
Kiyohara, C.1
Takayama, K.2
Nakanishi, Y.3
-
8
-
-
1342266756
-
The human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) DNA repair enzyme and its association with lung cancer risk
-
Park, J.; Chen, L.; Tockman, M.S.; Elahi, A.; Lazarus, P. The human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) DNA repair enzyme and its association with lung cancer risk. Pharmacogenetics, 2004, 14(2), 103-109.
-
(2004)
Pharmacogenetics
, vol.14
, Issue.2
, pp. 103-109
-
-
Park, J.1
Chen, L.2
Tockman, M.S.3
Elahi, A.4
Lazarus, P.5
-
9
-
-
34548292501
-
Base excision repair modulation as a risk factor for human cancers
-
Tudek, B. Base excision repair modulation as a risk factor for human cancers. Mol. Aspects Med., 2007, 28(3-4), 258-75.
-
(2007)
Mol. Aspects Med
, vol.28
, Issue.3-4
, pp. 258-275
-
-
Tudek, B.1
-
10
-
-
70449688321
-
The DNA repair gene APE1 T1349G polymorphism and cancer risk: A metaanalysis of 27 case-control studies
-
Gu, D.; Wang, M.; Wang, M.; Zhang, Z.; Chen, J. The DNA repair gene APE1 T1349G polymorphism and cancer risk: a metaanalysis of 27 case-control studies. Mutagenesis, 2009, 24(6), 507-512.
-
(2009)
Mutagenesis
, vol.24
, Issue.6
, pp. 507-512
-
-
Gu, D.1
Wang, M.2
Wang, M.3
Zhang, Z.4
Chen, J.5
-
11
-
-
13944281044
-
Polymorphic variation in hOGG1 and risk of cancer: A review of the functional and epidemiologic literature
-
Weiss, J.M.; Goode, E.L.; Ladiges, W.C.; Ulrich, C.M. Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature. Mol. Carcinog., 2005, 42(3), 127-141.
-
(2005)
Mol. Carcinog
, vol.42
, Issue.3
, pp. 127-141
-
-
Weiss, J.M.1
Goode, E.L.2
Ladiges, W.C.3
Ulrich, C.M.4
-
12
-
-
3943107573
-
Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints
-
Sancar, A.; Lindsey-Boltz, L.A.; Unsal-Kacmaz, K.; Linn, S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem., 2004, 73, 39-85.
-
(2004)
Annu. Rev. Biochem
, vol.73
, pp. 39-85
-
-
Sancar, A.1
Lindsey-Boltz, L.A.2
Unsal-Kacmaz, K.3
Linn, S.4
-
13
-
-
33847007529
-
The mechanics of base excision repair, and its relationship to aging and disease
-
Wilson, D.M. 3rd; Bohr, V.A. The mechanics of base excision repair, and its relationship to aging and disease. DNA Repair (Amst), 2007, 6(4), 544-559.
-
(2007)
DNA Repair (Amst)
, vol.6
, Issue.4
, pp. 544-559
-
-
Wilson 3rd., D.M.1
Bohr, V.A.2
-
14
-
-
34247599335
-
A unified view of base excision repair: Lesion-dependent protein complexes regulated by post-translational modification
-
Almeida, K.H.; Sobol, R.W. A unified view of base excision repair: lesion-dependent protein complexes regulated by post-translational modification. DNA Repair (Amst), 2007, 6 (6), 695-711.
-
(2007)
DNA Repair (Amst)
, vol.6
, Issue.6
, pp. 695-711
-
-
Almeida, K.H.1
Sobol, R.W.2
-
15
-
-
0345448125
-
Repair of abasic sites in DNA
-
Dianov, G.L.; Sleeth, K.M.; Dianova, II; Allinson, S.L. Repair of abasic sites in DNA. Mutat. Res., 2003, 53(1-2), 157-163.
-
(2003)
Mutat. Res
, vol.53
, Issue.1-2
, pp. 157-163
-
-
Dianov, G.L.1
Sleeth, K.M.2
Dianova, I.I.3
Allinson, S.L.4
-
16
-
-
34548276529
-
The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target
-
Fishel, M.L.; Kelley, M.R., The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target. Mol. Aspects Med., 2007, 28(3-4), 375-395.
-
(2007)
Mol. Aspects Med
, vol.28
, Issue.3-4
, pp. 375-395
-
-
Fishel, M.L.1
Kelley, M.R.2
-
17
-
-
77955095659
-
endonuclease 1 (APE1): From mechanistic insights to druggable target in cancer
-
Abbotts, R.; Madhusudan, S. Human AP endonuclease 1 (APE1): From mechanistic insights to druggable target in cancer. Cancer Treat. Rev., 2010, 36(5), 425-35.
-
(2010)
Cancer Treat. Rev
, vol.36
, Issue.5
, pp. 425-435
-
-
Abbotts, R.1
Madhusudan, S.2
Human, A.P.3
-
18
-
-
58849147871
-
Going ape as an approach to cancer therapeutics
-
Bapat, A.; Fishel, M.L.; Kelley, M.R., Going ape as an approach to cancer therapeutics. Antioxid. Redox Signal., 2009, 11(3), 651-668.
-
(2009)
Antioxid. Redox Signal
, vol.11
, Issue.3
, pp. 651-668
-
-
Bapat, A.1
Fishel, M.L.2
Kelley, M.R.3
-
19
-
-
0029829265
-
The redox/DNA repair protein, Ref-1, is essential for early embryonic development in mice
-
Xanthoudakis, S.; Smeyne, R.J.; Wallace, J.D.; Curran, T. The redox/DNA repair protein, Ref-1, is essential for early embryonic development in mice. Proc. Natl. Acad. Sci. USA, 1996, 93(17), 8919-8923.
-
(1996)
Proc. Natl. Acad. Sci. USA
, vol.93
, Issue.17
, pp. 8919-8923
-
-
Xanthoudakis, S.1
Smeyne, R.J.2
Wallace, J.D.3
Curran, T.4
-
20
-
-
0036718792
-
The apurinic/apyrimidinic endonuclease activity of Ape1/Ref-1 contributes to human glioma cell resistance to alkylating agents and is elevated by oxidative stress
-
Silber, J.R.; Bobola, M.S.; Blank, A.; Schoeler, K.D.; Haroldson, P.D.; Huynh, M.B.; Kolstoe, D.D. The apurinic/apyrimidinic endonuclease activity of Ape1/Ref-1 contributes to human glioma cell resistance to alkylating agents and is elevated by oxidative stress. Clin. Cancer Res., 2002, 8(9), 3008-3018.
-
(2002)
Clin. Cancer Res
, vol.8
, Issue.9
, pp. 3008-3018
-
-
Silber, J.R.1
Bobola, M.S.2
Blank, A.3
Schoeler, K.D.4
Haroldson, P.D.5
Huynh, M.B.6
Kolstoe, D.D.7
-
21
-
-
4444327784
-
Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: Enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition
-
Wang, D.; Luo, M.; Kelley, M.R. Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition. Mol. Cancer Ther., 2004, 3(6), 679-686.
-
(2004)
Mol. Cancer Ther
, vol.3
, Issue.6
, pp. 679-686
-
-
Wang, D.1
Luo, M.2
Kelley, M.R.3
-
22
-
-
27144474248
-
Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors
-
Bobola, M.S.; Finn, L.S.; Ellenbogen, R.G.; Geyer, J.R.; Berger, M.S.; Braga, J.M.; Meade, E.H.; Gross, M.E.; Silber, J.R. Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors. Clin. Cancer Res., 2005, 11(20), 7405-7414.
-
(2005)
Clin. Cancer Res
, vol.11
, Issue.20
, pp. 7405-7414
-
-
Bobola, M.S.1
Finn, L.S.2
Ellenbogen, R.G.3
Geyer, J.R.4
Berger, M.S.5
Braga, J.M.6
Meade, E.H.7
Gross, M.E.8
Silber, J.R.9
-
23
-
-
5044238690
-
Effects of gemcitabine on APE/ref-1 endonuclease activity in pancreatic cancer cells, and the therapeutic potential of antisense oligonucleotides
-
Lau, J.P.; Weatherdon, K.L.; Skalski, V.; Hedley, D.W. Effects of gemcitabine on APE/ref-1 endonuclease activity in pancreatic cancer cells, and the therapeutic potential of antisense oligonucleotides. Br. J. Cancer, 2004, 91(6), 1166-1173.
-
(2004)
Br. J. Cancer
, vol.91
, Issue.6
, pp. 1166-1173
-
-
Lau, J.P.1
Weatherdon, K.L.2
Skalski, V.3
Hedley, D.W.4
-
24
-
-
0028244814
-
Stable expression in rat glioma cells of sense and antisense nucleic acids to a human multifunctional DNA repair enzyme, APEX nuclease
-
Ono, Y.; Furuta, T.; Ohmoto, T.; Akiyama, K.; Seki, S., Stable expression in rat glioma cells of sense and antisense nucleic acids to a human multifunctional DNA repair enzyme, APEX nuclease. Mutat. Res., 1994, 315(1), 55-63.
-
(1994)
Mutat. Res
, vol.315
, Issue.1
, pp. 55-63
-
-
Ono, Y.1
Furuta, T.2
Ohmoto, T.3
Akiyama, K.4
Seki, S.5
-
25
-
-
0028596574
-
A role for the human DNA repair enzyme HAP1 in cellular protection against DNA damaging agents and hypoxic stress
-
Walker, L.J.; Craig, R.B.; Harris, A.L.; Hickson, I.D., A role for the human DNA repair enzyme HAP1 in cellular protection against DNA damaging agents and hypoxic stress. Nucleic Acids Res., 1994, 22(23), 4884-4889.
-
(1994)
Nucleic Acids Res
, vol.22
, Issue.23
, pp. 4884-4889
-
-
Walker, L.J.1
Craig, R.B.2
Harris, A.L.3
Hickson, I.D.4
-
26
-
-
70350622182
-
APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells
-
Wang, D.; Xiang, D.B.; Yang, X.Q.; Chen, L.S.; Li, M.X.; Zhong, Z.Y.; Zhang, Y.S. APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells. Lung Cancer, 2009, 66(3), 298-304.
-
(2009)
Lung Cancer
, vol.66
, Issue.3
, pp. 298-304
-
-
Wang, D.1
Xiang, D.B.2
Yang, X.Q.3
Chen, L.S.4
Li, M.X.5
Zhong, Z.Y.6
Zhang, Y.S.7
-
27
-
-
73749084430
-
Increase the cisplatin cytotoxicity and cisplatin-induced DNA damage in HepG2 cells by XRCC1 abrogation related mechanisms
-
Zhang, R.; Niu, Y.; Zhou, Y. Increase the cisplatin cytotoxicity and cisplatin-induced DNA damage in HepG2 cells by XRCC1 abrogation related mechanisms. Toxicol. Lett., 2010, 192(2), 108-114.
-
(2010)
Toxicol. Lett
, vol.192
, Issue.2
, pp. 108-114
-
-
Zhang, R.1
Niu, Y.2
Zhou, Y.3
-
28
-
-
0034676227
-
Going APE over ref- 1
-
Evans, A.R.; Limp-Foster, M.; Kelley, M.R., Going APE over ref- 1. Mutat. Res., 2000, 461(2), 83-108.
-
(2000)
Mutat. Res
, vol.461
, Issue.2
, pp. 83-108
-
-
Evans, A.R.1
Limp-Foster, M.2
Kelley, M.R.3
-
29
-
-
33847666362
-
Intracellular trafficking and regulation of mammalian AP-endonuclease 1 (APE1), an essential DNA repair protein
-
Mitra, S.; Izumi, T.; Boldogh, I.; Bhakat, K.K.; Chattopadhyay, R.; Szczesny, B., Intracellular trafficking and regulation of mammalian AP-endonuclease 1 (APE1), an essential DNA repair protein. DNA Repair (Amst), 2007, 6(4), 461-469.
-
(2007)
DNA Repair (Amst)
, vol.6
, Issue.4
, pp. 461-469
-
-
Mitra, S.1
Izumi, T.2
Boldogh, I.3
Bhakat, K.K.4
Chattopadhyay, R.5
Szczesny, B.6
-
30
-
-
14044269479
-
The intracellular localization of APE1/Ref-1: More than a passive phenomenon?
-
Tell, G.; Damante, G.; Caldwell, D.; Kelley, M.R., The intracellular localization of APE1/Ref-1: more than a passive phenomenon? Antioxid. Redox. Signal., 2005, 7(3-4), 367-384.
-
(2005)
Antioxid. Redox. Signal
, vol.7
, Issue.3-4
, pp. 367-384
-
-
Tell, G.1
Damante, G.2
Caldwell, D.3
Kelley, M.R.4
-
31
-
-
0034668113
-
Functional characterization of Ape1 variants identified in the human population
-
Hadi, M.Z.; Coleman, M.A.; Fidelis, K.; Mohrenweiser, H.W.; Wilson, D.M. 3rd. Functional characterization of Ape1 variants identified in the human population. Nucleic Acids Res., 2000, 28(20), 3871-3879.
-
(2000)
Nucleic Acids Res
, vol.28
, Issue.20
, pp. 3871-3879
-
-
Hadi, M.Z.1
Coleman, M.A.2
Fidelis, K.3
Mohrenweiser, H.W.4
Wilson 3rd., D.M.5
-
32
-
-
70349655091
-
Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility
-
Lu, J.; Zhang, S.; Chen, D.; Wang, H.; Wu, W.; Wang, X.; Lei, Y.; Wang, J.; Qian, J.; Fan, W.; Hu, Z.; Jin, L.; Shen, H.; Huang, W.; Wei, Q.; Lu, D. Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility. FASEB J., 2009, 23(10), 3459-3469.
-
(2009)
FASEB J
, vol.23
, Issue.10
, pp. 3459-3469
-
-
Lu, J.1
Zhang, S.2
Chen, D.3
Wang, H.4
Wu, W.5
Wang, X.6
Lei, Y.7
Wang, J.8
Qian, J.9
Fan, W.10
Hu, Z.11
Jin, L.12
Shen, H.13
Huang, W.14
Wei, Q.15
Lu, D.16
-
33
-
-
0041378046
-
XRCC1 and DNA strand break repair
-
Caldecott, K.W. XRCC1 and DNA strand break repair. DNA Repair (Amst), 2003, 2(9), 955-969.
-
(2003)
DNA Repair (Amst)
, vol.2
, Issue.9
, pp. 955-969
-
-
Caldecott, K.W.1
-
34
-
-
0033561152
-
Requirement for the Xrcc1 DNA base excision repair gene during early mouse development
-
Tebbs, R.S.; Flannery, M.L.; Meneses, J.J.; Hartmann, A.; Tucker, J.D.; Thompson, L. H.; Cleaver, J.E.; Pedersen, R.A. Requirement for the Xrcc1 DNA base excision repair gene during early mouse development. Dev Biol., 1999, 208(2), 513-529.
-
(1999)
Dev Biol
, vol.208
, Issue.2
, pp. 513-529
-
-
Tebbs, R.S.1
Flannery, M.L.2
Meneses, J.J.3
Hartmann, A.4
Tucker, J.D.5
Thompson, L.H.6
Cleaver, J.E.7
Pedersen, R.A.8
-
35
-
-
15244341766
-
Micronuclei in EM9 cells expressing polymorphic forms of human XRCC1
-
Qu, T.; Morii, E.; Oboki, K.; Lu, Y.; Morimoto, K. Micronuclei in EM9 cells expressing polymorphic forms of human XRCC1. Cancer Lett., 2005, 221(1), 91-95.
-
(2005)
Cancer Lett
, vol.221
, Issue.1
, pp. 91-95
-
-
Qu, T.1
Morii, E.2
Oboki, K.3
Lu, Y.4
Morimoto, K.5
-
36
-
-
0346243565
-
Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays
-
Au, W.W.; Salama, S.A.; Sierra-Torres, C.H. Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ. Health Perspect., 2003, 111(15), 1843-1850.
-
(2003)
Environ. Health Perspect
, vol.111
, Issue.15
, pp. 1843-1850
-
-
Au, W.W.1
Salama, S.A.2
Sierra-Torres, C.H.3
-
37
-
-
0036208101
-
Central role for the XRCC1 BRCT I domain in mammalian DNA single-strand break repair
-
Taylor, R.M.; Thistlethwaite, A.; Caldecott, K.W. Central role for the XRCC1 BRCT I domain in mammalian DNA single-strand break repair. Mol. Cell Biol., 2002, 22(8), 2556-2563.
-
(2002)
Mol. Cell Biol
, vol.22
, Issue.8
, pp. 2556-2563
-
-
Taylor, R.M.1
Thistlethwaite, A.2
Caldecott, K.W.3
-
38
-
-
33645116504
-
Mouse models of XRCC1 DNA repair polymorphisms and cancer
-
Ladiges, W.C. Mouse models of XRCC1 DNA repair polymorphisms and cancer. Oncogene, 2006, 25(11), 1612-1619.
-
(2006)
Oncogene
, vol.25
, Issue.11
, pp. 1612-1619
-
-
Ladiges, W.C.1
-
39
-
-
69249220333
-
XRCC1 genetic polymorphism Arg399Gln and prostate cancer risk: A metaanalysis
-
Geng, J.; Zhang, Q.; Zhu, C.; Wang, J.; Chen, L. XRCC1 genetic polymorphism Arg399Gln and prostate cancer risk: a metaanalysis. Urology, 2009, 74(3), 648-653.
-
(2009)
Urology
, vol.74
, Issue.3
, pp. 648-653
-
-
Geng, J.1
Zhang, Q.2
Zhu, C.3
Wang, J.4
Chen, L.5
-
40
-
-
67349253065
-
XRCC1 gene polymorphisms and breast cancer risk in different populations: A meta-analysis
-
Li, H.; Ha, T.C.; Tai, B.C. XRCC1 gene polymorphisms and breast cancer risk in different populations: a meta-analysis. Breast, 2009, 18(3), 183-191.
-
(2009)
Breast
, vol.18
, Issue.3
, pp. 183-191
-
-
Li, H.1
Ha, T.C.2
Tai, B.C.3
-
41
-
-
56049094384
-
XRCC1 polymorphism and lung cancer risk
-
Schneider, J.; Classen, V.; Helmig, S., XRCC1 polymorphism and lung cancer risk. Expert Rev. Mol. Diagn., 2008, 8(6), 761-780.
-
(2008)
Expert Rev. Mol. Diagn
, vol.8
, Issue.6
, pp. 761-780
-
-
Schneider, J.1
Classen, V.2
Helmig, S.3
-
42
-
-
45849105603
-
Genetic polymorphisms and head and neck cancer risk (Review)
-
Hiyama, T.; Yoshihara, M.; Tanaka, S.; Chayama, K. Genetic polymorphisms and head and neck cancer risk (Review). Int. J. Oncol., 2008, 32(5), 945-973.
-
(2008)
Int. J. Oncol
, vol.32
, Issue.5
, pp. 945-973
-
-
Hiyama, T.1
Yoshihara, M.2
Tanaka, S.3
Chayama, K.4
-
43
-
-
77952544071
-
The prognostic significance of ERCC1, BRCA1, XRCC1, and betaIII-tubulin expression in patients with non-small cell lung cancer treated by platinum- and taxane-based neoadjuvant chemotherapy and surgical resection
-
Kang, C.H.; Jang, B.G.; Kim, D.W.; Chung, D.H.; Kim, Y.T.; Jheon, S.; Sung, S.W.; Kim, J.H. The prognostic significance of ERCC1, BRCA1, XRCC1, and betaIII-tubulin expression in patients with non-small cell lung cancer treated by platinum- and taxane-based neoadjuvant chemotherapy and surgical resection. Lung Cancer, 2010, 68(3), 478-483.
-
(2010)
Lung Cancer
, vol.68
, Issue.3
, pp. 478-483
-
-
Kang, C.H.1
Jang, B.G.2
Kim, D.W.3
Chung, D.H.4
Kim, Y.T.5
Jheon, S.6
Sung, S.W.7
Kim, J.H.8
-
44
-
-
45749127481
-
Predictive biomarkers of chemotherapy efficacy in colorectal cancer: Results from the UK MRC FOCUS trial
-
Braun, M.S.; Richman, S.D.; Quirke, P.; Daly, C.; Adlard, J.W.; Elliott, F.; Barrett, J.H.; Selby, P.; Meade, A. M.; Stephens, R.J.; Parmar, M.K.; Seymour, M.T. Predictive biomarkers of chemotherapy efficacy in colorectal cancer: results from the UK MRC FOCUS trial. J. Clin. Oncol., 2008, 26(16), 2690-2698.
-
(2008)
J. Clin. Oncol
, vol.26
, Issue.16
, pp. 2690-2698
-
-
Braun, M.S.1
Richman, S.D.2
Quirke, P.3
Daly, C.4
Adlard, J.W.5
Elliott, F.6
Barrett, J.H.7
Selby, P.8
Meade, A.M.9
Stephens, R.J.10
Parmar, M.K.11
Seymour, M.T.12
-
45
-
-
73949096486
-
Association of molecular markers with toxicity outcomes in a randomized trial of chemotherapy for advanced colorectal cancer: The FOCUS trial
-
Braun, M.S.; Richman, S.D.; Thompson, L.; Daly, C.L.; Meade, A.M.; Adlard, J.W.; Allan, J.M.; Parmar, M.K.; Quirke, P.; Seymour, M.T. Association of molecular markers with toxicity outcomes in a randomized trial of chemotherapy for advanced colorectal cancer: the FOCUS trial. J. Clin. Oncol., 2009, 27(33), 5519-5528.
-
(2009)
J. Clin. Oncol
, vol.27
, Issue.33
, pp. 5519-5528
-
-
Braun, M.S.1
Richman, S.D.2
Thompson, L.3
Daly, C.L.4
Meade, A.M.5
Adlard, J.W.6
Allan, J.M.7
Parmar, M.K.8
Quirke, P.9
Seymour, M.T.10
-
46
-
-
67249087934
-
polymerase beta polymorphism, Arg137Gln, impairs its polymerase activity and interaction with PCNA and the cellular base excision repair capacity
-
Guo, Z.; Zheng, L.; Dai, H.; Zhou, M.; Xu, H.; Shen, B. Human DNA polymerase beta polymorphism, Arg137Gln, impairs its polymerase activity and interaction with PCNA and the cellular base excision repair capacity. Nucleic Acids Res., 2009, 37(10), 3431-3441.
-
(2009)
Nucleic Acids Res
, vol.37
, Issue.10
, pp. 3431-3441
-
-
Guo, Z.1
Zheng, L.2
Dai, H.3
Zhou, M.4
Xu, H.5
Shen, B.6
Human, D.N.A.7
-
47
-
-
33947156771
-
Effects of base excision repair gene polymorphisms on pancreatic cancer survival
-
Li, D.; Li, Y.; Jiao, L.; Chang, D.Z.; Beinart, G.; Wolff, R.A.; Evans, D.B.; Hassan, M. M.; Abbruzzese, J.L. Effects of base excision repair gene polymorphisms on pancreatic cancer survival. Int. J. Cancer, 2007, 120(8), 1748-1754.
-
(2007)
Int. J. Cancer
, vol.120
, Issue.8
, pp. 1748-1754
-
-
Li, D.1
Li, Y.2
Jiao, L.3
Chang, D.Z.4
Beinart, G.5
Wolff, R.A.6
Evans, D.B.7
Hassan, M.M.8
Abbruzzese, J.L.9
-
48
-
-
77953772492
-
Possible associations of APE1 polymorphism with susceptibility and HOGG1 polymorphism with prognosis in gastric cancer
-
Canbay, E.; Agachan, B.; Gulluoglu, M.; Isbir, T.; Balik, E.; Yamaner, S.; Bulut, T.; Cacina, C.; Eraltan, I.Y.; Yilmaz, A.; Bugra, D. Possible associations of APE1 polymorphism with susceptibility and HOGG1 polymorphism with prognosis in gastric cancer. Anticancer Res., 2010, 30(4), 1359-1364.
-
(2010)
Anticancer Res
, vol.30
, Issue.4
, pp. 1359-1364
-
-
Canbay, E.1
Agachan, B.2
Gulluoglu, M.3
Isbir, T.4
Balik, E.5
Yamaner, S.6
Bulut, T.7
Cacina, C.8
Eraltan, I.Y.9
Yilmaz, A.10
Bugra, D.11
-
49
-
-
33747344251
-
Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer
-
Wu, X.; Gu, J.; Wu, T.T.; Swisher, S.G.; Liao, Z.; Correa, A.M.; Liu, J.; Etzel, C.J.; Amos, C.I.; Huang, M.; Chiang, S.S.; Milas, L.; Hittelman, W.N.; Ajani, J.A. Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer. J. Clin. Oncol., 2006, 24(23), 3789-3798.
-
(2006)
J. Clin. Oncol
, vol.24
, Issue.23
, pp. 3789-3798
-
-
Wu, X.1
Gu, J.2
Wu, T.T.3
Swisher, S.G.4
Liao, Z.5
Correa, A.M.6
Liu, J.7
Etzel, C.J.8
Amos, C.I.9
Huang, M.10
Chiang, S.S.11
Milas, L.12
Hittelman, W.N.13
Ajani, J.A.14
-
50
-
-
28644440431
-
Polymorphisms of the human OGG1 gene in laryngeal cancer: Implications in radiotherapy response and survival
-
Monteiro, E.; Varzim, G.; Silva, R.; da Costa, B.; Lopes, C. Polymorphisms of the human OGG1 gene in laryngeal cancer: implications in radiotherapy response and survival. Rev. Laryngol. Otol. Rhinol. (Bord), 2005, 126(3), 135-140.
-
(2005)
Rev. Laryngol. Otol. Rhinol. (Bord)
, vol.126
, Issue.3
, pp. 135-140
-
-
Monteiro, E.1
Varzim, G.2
Silva, R.3
da Costa, B.4
Lopes, C.5
-
51
-
-
0028969271
-
Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)
-
Cox, J.D.; Stetz, J.; Pajak, T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int. J. Radiat. Oncol. Biol. Phys., 1995, 31(5), 1341-1346.
-
(1995)
Int. J. Radiat. Oncol. Biol. Phys
, vol.31
, Issue.5
, pp. 1341-1346
-
-
Cox, J.D.1
Stetz, J.2
Pajak, T.F.3
-
52
-
-
70449585523
-
Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor
-
Zhang, Y.; Wang, J.; Xiang, D.; Wang, D.; Xin, X. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor. Int. J. Oncol., 2009, 35(5), 1069-1079.
-
(2009)
Int. J. Oncol
, vol.35
, Issue.5
, pp. 1069-1079
-
-
Zhang, Y.1
Wang, J.2
Xiang, D.3
Wang, D.4
Xin, X.5
-
53
-
-
0035570805
-
Prognostic significance of Ape1/ref-1 subcellular localization in non-small cell lung carcinomas
-
Puglisi, F.; Aprile, G.; Minisini, A.M.; Barbone, F.; Cataldi, P.; Tell, G.; Kelley, M.R.; Damante, G.; Beltrami, C.A.; Di Loreto, C. Prognostic significance of Ape1/ref-1 subcellular localization in non-small cell lung carcinomas. Anticancer Res., 2001, 21(6A), 4041-4049.
-
(2001)
Anticancer Res
, vol.21
, Issue.6 A
, pp. 4041-4049
-
-
Puglisi, F.1
Aprile, G.2
Minisini, A.M.3
Barbone, F.4
Cataldi, P.5
Tell, G.6
Kelley, M.R.7
Damante, G.8
Beltrami, C.A.9
Di Loreto, C.10
-
54
-
-
76949094198
-
Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers
-
Al-Attar, A.; Gossage, L.; Fareed, K.R.; Shehata, M.; Mohammed, M.; Zaitoun, A.M.; Soomro, I.; Lobo, D.N.; Abbotts, R.; Chan, S.; Madhusudan, S. Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers. Br. J. Cancer, 2010, 102(4), 704-709.
-
(2010)
Br. J. Cancer
, vol.102
, Issue.4
, pp. 704-709
-
-
Al-Attar, A.1
Gossage, L.2
Fareed, K.R.3
Shehata, M.4
Mohammed, M.5
Zaitoun, A.M.6
Soomro, I.7
Lobo, D.N.8
Abbotts, R.9
Chan, S.10
Madhusudan, S.11
-
55
-
-
77952888002
-
Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy
-
Fareed, K.R.; Al-Attar, A.; Soomro, I.N.; Kaye, P.V.; Patel, J.; Lobo, D.N.; Parsons, S. L.; Madhusudan, S. Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy. Br. J. Cancer, 2010, 102(11), 1600-1607.
-
(2010)
Br. J. Cancer
, vol.102
, Issue.11
, pp. 1600-1607
-
-
Fareed, K.R.1
Al-Attar, A.2
Soomro, I.N.3
Kaye, P.V.4
Patel, J.5
Lobo, D.N.6
Parsons, S.L.7
Madhusudan, S.8
-
56
-
-
0035341476
-
Nuclear expression of human apurinic/apyrimidinic endonuclease (HAP1/Ref-1) in head-and-neck cancer is associated with resistance to chemoradiotherapy and poor outcome
-
Koukourakis, M.I.; Giatromanolaki, A.; Kakolyris, S.; Sivridis, E.; Georgoulias, V.; Funtzilas, G.; Hickson, I.D.; Gatter, K.C.; Harris, A.L. Nuclear expression of human apurinic/apyrimidinic endonuclease (HAP1/Ref-1) in head-and-neck cancer is associated with resistance to chemoradiotherapy and poor outcome. Int. J. Radiat. Oncol. Biol. Phys., 2001, 50(1), 27-36.
-
(2001)
Int. J. Radiat. Oncol. Biol. Phys
, vol.50
, Issue.1
, pp. 27-36
-
-
Koukourakis, M.I.1
Giatromanolaki, A.2
Kakolyris, S.3
Sivridis, E.4
Georgoulias, V.5
Funtzilas, G.6
Hickson, I.D.7
Gatter, K.C.8
Harris, A.L.9
-
57
-
-
43049102429
-
Alteration of APE1/ref-1 expression in non-small cell lung cancer: The implications of impaired extracellular superoxide dismutase and catalase antioxidant systems
-
Yoo, D.G.; Song, Y.J.; Cho, E.J.; Lee, S.K.; Park, J.B.; Yu, J.H.; Lim, S.P.; Kim, J.M.; Jeon, B.H. Alteration of APE1/ref-1 expression in non-small cell lung cancer: the implications of impaired extracellular superoxide dismutase and catalase antioxidant systems. Lung Cancer, 2008, 60(2), 277-284.
-
(2008)
Lung Cancer
, vol.60
, Issue.2
, pp. 277-284
-
-
Yoo, D.G.1
Song, Y.J.2
Cho, E.J.3
Lee, S.K.4
Park, J.B.5
Yu, J.H.6
Lim, S.P.7
Kim, J.M.8
Jeon, B.H.9
-
58
-
-
9744268998
-
Apurinic endonuclease activity in adult gliomas and time to tumor progression after alkylating agent-based chemotherapy and after radiotherapy
-
Bobola, M.S.; Emond, M.J.; Blank, A.; Meade, E.H.; Kolstoe, D.D.; Berger, M.S.; Rostomily, R.C.; Silbergeld, D.L.; Spence, A.M.; Silber, J.R. Apurinic endonuclease activity in adult gliomas and time to tumor progression after alkylating agent-based chemotherapy and after radiotherapy. Clin. Cancer Res., 2004, 10(23), 7875-7883.
-
(2004)
Clin. Cancer Res
, vol.10
, Issue.23
, pp. 7875-7883
-
-
Bobola, M.S.1
Emond, M.J.2
Blank, A.3
Meade, E.H.4
Kolstoe, D.D.5
Berger, M.S.6
Rostomily, R.C.7
Silbergeld, D.L.8
Spence, A.M.9
Silber, J.R.10
-
59
-
-
0034905642
-
Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer
-
Kelley, M.R.; Cheng, L.; Foster, R.; Tritt, R.; Jiang, J.; Broshears, J.; Koch, M. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer. Clin. Cancer Res., 2001, 7(4), 824-830.
-
(2001)
Clin. Cancer Res
, vol.7
, Issue.4
, pp. 824-830
-
-
Kelley, M.R.1
Cheng, L.2
Foster, R.3
Tritt, R.4
Jiang, J.5
Broshears, J.6
Koch, M.7
-
60
-
-
7844241550
-
Levels of the DNA repair enzyme human apurinic/apyrimidinic endonuclease (APE1, APEX, Ref-1) are associated with the intrinsic radiosensitivity of cervical cancers
-
Herring, C.J.; West, C.M.; Wilks, D.P.; Davidson, S.E.; Hunter, R.D.; Berry, P.; Forster, G.; MacKinnon, J.; Rafferty, J.A.; Elder, R.H.; Hendry, J.H.; Margison, G.P. Levels of the DNA repair enzyme human apurinic/apyrimidinic endonuclease (APE1, APEX, Ref-1) are associated with the intrinsic radiosensitivity of cervical cancers. Br. J. Cancer, 1998, 78(9), 1128-1133.
-
(1998)
Br. J. Cancer
, vol.78
, Issue.9
, pp. 1128-1133
-
-
Herring, C.J.1
West, C.M.2
Wilks, D.P.3
Davidson, S.E.4
Hunter, R.D.5
Berry, P.6
Forster, G.7
Mackinnon, J.8
Rafferty, J.A.9
Elder, R.H.10
Hendry, J.H.11
Margison, G.P.12
-
61
-
-
0035266131
-
Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation
-
Robertson, K.A.; Bullock, H.A.; Xu, Y.; Tritt, R.; Zimmerman, E.; Ulbright, T.M.; Foster, R.S.; Einhorn, L.H.; Kelley, M.R. Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation. Cancer Res., 2001, 61(5), 2220-2225.
-
(2001)
Cancer Res
, vol.61
, Issue.5
, pp. 2220-2225
-
-
Robertson, K.A.1
Bullock, H.A.2
Xu, Y.3
Tritt, R.4
Zimmerman, E.5
Ulbright, T.M.6
Foster, R.S.7
Einhorn, L.H.8
Kelley, M.R.9
-
62
-
-
34247172071
-
Genetic polymorphisms and treatment response in advanced non-small cell lung cancer
-
Su, D.; Ma, S.; Liu, P.; Jiang, Z.; Lv, W.; Zhang, Y.; Deng, Q.; Smith, S.; Yu, H. Genetic polymorphisms and treatment response in advanced non-small cell lung cancer. Lung Cancer, 2007, 56(2), 281-288.
-
(2007)
Lung Cancer
, vol.56
, Issue.2
, pp. 281-288
-
-
Su, D.1
Ma, S.2
Liu, P.3
Jiang, Z.4
Lv, W.5
Zhang, Y.6
Deng, Q.7
Smith, S.8
Yu, H.9
-
63
-
-
34247374739
-
Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trials
-
Kuptsova, N.; Kopecky, K.J.; Godwin, J.; Anderson, J.; Hoque, A.; Willman, C.L.; Slovak, M.L.; Ambrosone, C.B. Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trials. Blood, 2007, 109(9), 3936-3944.
-
(2007)
Blood
, vol.109
, Issue.9
, pp. 3936-3944
-
-
Kuptsova, N.1
Kopecky, K.J.2
Godwin, J.3
Anderson, J.4
Hoque, A.5
Willman, C.L.6
Slovak, M.L.7
Ambrosone, C.B.8
-
64
-
-
58549098021
-
Single nucleotide polymorphisms in DNA repair genes XRCC1 and APEX1 in progression and survival of primary cutaneous melanoma patients
-
Figl, A.; Scherer, D.; Nagore, E.; Bermejo, J.L.; Dickes, E.; Thirumaran, R.K.; Gast, A.; Hemminki, K.; Kumar, R.; Schadendorf, D. Single nucleotide polymorphisms in DNA repair genes XRCC1 and APEX1 in progression and survival of primary cutaneous melanoma patients. Mutat. Res., 2009, 661(1-2), 78-84.
-
(2009)
Mutat. Res
, vol.661
, Issue.1-2
, pp. 78-84
-
-
Figl, A.1
Scherer, D.2
Nagore, E.3
Bermejo, J.L.4
Dickes, E.5
Thirumaran, R.K.6
Gast, A.7
Hemminki, K.8
Kumar, R.9
Schadendorf, D.10
-
65
-
-
77952315609
-
Lack of influence of XRCC1 and XPD gene polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancers
-
Yao, C.Y.; Huang, X.E.; Li, C.; Shen, H.B.; Shi, M.Q.; Feng, J.F.; Pan, L.X.; Tang, J.H. Lack of influence of XRCC1 and XPD gene polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancers. Asian Pac. J. Cancer Prev., 2009, 10(5), 859-864.
-
(2009)
Asian Pac. J. Cancer Prev
, vol.10
, Issue.5
, pp. 859-864
-
-
Yao, C.Y.1
Huang, X.E.2
Li, C.3
Shen, H.B.4
Shi, M.Q.5
Feng, J.F.6
Pan, L.X.7
Tang, J.H.8
-
66
-
-
34848869833
-
Which gene is a dominant predictor of response during FOLFOX chemotherapy for the treatment of metastatic colorectal cancer, the MTHFR or XRCC1 gene?
-
Suh, K.W.; Kim, J.H.; Kim do, Y.; Kim, Y.B.; Lee, C.; Choi, S. Which gene is a dominant predictor of response during FOLFOX chemotherapy for the treatment of metastatic colorectal cancer, the MTHFR or XRCC1 gene? Ann. Surg. Oncol., 2006, 13(11), 1379-1385.
-
(2006)
Ann. Surg. Oncol
, vol.13
, Issue.11
, pp. 1379-1385
-
-
Suh, K.W.1
Kim, J.H.2
Kim do, Y.3
Kim, Y.B.4
Lee, C.5
Choi, S.6
-
67
-
-
0035174375
-
A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer
-
Stoehlmacher, J.; Ghaderi, V.; Iobal, S.; Groshen, S.; Tsao-Wei, D.; Park, D.; Lenz, H.J. A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer. Anticancer Res., 2001, 21(4B), 3075-3079.
-
(2001)
Anticancer Res
, vol.21
, Issue.4 B
, pp. 3075-3079
-
-
Stoehlmacher, J.1
Ghaderi, V.2
Iobal, S.3
Groshen, S.4
Tsao-Wei, D.5
Park, D.6
Lenz, H.J.7
-
68
-
-
16644395637
-
Single nucleotide polymorphisms in XRCC1 and clinical response to platin-based chemotherapy in advanced non-small cell lung cancer
-
Wang, Z.H.; Miao, X.P.; Tan, W.; Zhang, X.R.; Xu, B.H.; Lin, D.X. Single nucleotide polymorphisms in XRCC1 and clinical response to platin-based chemotherapy in advanced non-small cell lung cancer. Ai Zheng, 2004, 23(8), 865-868.
-
(2004)
Ai Zheng
, vol.23
, Issue.8
, pp. 865-868
-
-
Wang, Z.H.1
Miao, X.P.2
Tan, W.3
Zhang, X.R.4
Xu, B.H.5
Lin, D.X.6
-
69
-
-
4344567395
-
XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced nonsmall- cell lung cancer patients treated with platinum chemotherapy
-
Gurubhagavatula, S.; Liu, G.; Park, S.; Zhou, W.; Su, L.; Wain, J.C.; Lynch, T.J.; Neuberg, D.S.; Christiani, D.C. XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced nonsmall- cell lung cancer patients treated with platinum chemotherapy. J. Clin. Oncol., 2004, 22(13), 2594-2601.
-
(2004)
J. Clin. Oncol
, vol.22
, Issue.13
, pp. 2594-2601
-
-
Gurubhagavatula, S.1
Liu, G.2
Park, S.3
Zhou, W.4
Su, L.5
Wain, J.C.6
Lynch, T.J.7
Neuberg, D.S.8
Christiani, D.C.9
-
70
-
-
33645298447
-
Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients
-
de las Penas, R.; Sanchez-Ronco, M.; Alberola, V.; Taron, M.; Camps, C.; Garcia-Carbonero, R.; Massuti, B.; Queralt, C.; Botia, M.; Garcia-Gomez, R.; Isla, D.; Cobo, M.; Santarpia, M.; Cecere, F.; Mendez, P.; Sanchez, J.J.; Rosell, R. Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients. Ann. Oncol., 2006, 17(4), 668-675.
-
(2006)
Ann. Oncol
, vol.17
, Issue.4
, pp. 668-675
-
-
de las Penas, R.1
Sanchez-Ronco, M.2
Alberola, V.3
Taron, M.4
Camps, C.5
Garcia-Carbonero, R.6
Massuti, B.7
Queralt, C.8
Botia, M.9
Garcia-Gomez, R.10
Isla, D.11
Cobo, M.12
Santarpia, M.13
Cecere, F.14
Mendez, P.15
Sanchez, J.J.16
Rosell, R.17
-
71
-
-
41849098567
-
Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India
-
Sreeja, L.; Syamala, V.S.; Syamala, V.; Hariharan, S.; Raveendran, P.B.; Vijayalekshmi, R.V.; Madhavan, J.; Ankathil, R. Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India. J. Cancer Res. Clin. Oncol., 2008, 134(6), 645-652.
-
(2008)
J. Cancer Res. Clin. Oncol
, vol.134
, Issue.6
, pp. 645-652
-
-
Sreeja, L.1
Syamala, V.S.2
Syamala, V.3
Hariharan, S.4
Raveendran, P.B.5
Vijayalekshmi, R.V.6
Madhavan, J.7
Ankathil, R.8
-
72
-
-
78549288382
-
Correlation of the sensitivity of NP chemotherapy in non-small lung cancer with DNA repair gene XRCC1 polymorphism
-
Hong, C.Y.; Xu, Q.; Yue, Z.; Zhang, Y.; Yuan, Y. Correlation of the sensitivity of NP chemotherapy in non-small lung cancer with DNA repair gene XRCC1 polymorphism. Ai Zheng, 2009, 28(12), 1291-1297.
-
(2009)
Ai Zheng
, vol.28
, Issue.12
, pp. 1291-1297
-
-
Hong, C.Y.1
Xu, Q.2
Yue, Z.3
Zhang, Y.4
Yuan, Y.5
-
73
-
-
34249812370
-
Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer
-
Giachino, D.F.; Ghio, P.; Regazzoni, S.; Mandrile, G.; Novello, S.; Selvaggi, G.; Gregori, D.; DeMarchi, M.; Scagliotti, G.V. Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer. Clin. Cancer Res., 2007, 13(10), 2876-2881.
-
(2007)
Clin. Cancer Res
, vol.13
, Issue.10
, pp. 2876-2881
-
-
Giachino, D.F.1
Ghio, P.2
Regazzoni, S.3
Mandrile, G.4
Novello, S.5
Selvaggi, G.6
Gregori, D.7
Demarchi, M.8
Scagliotti, G.V.9
-
74
-
-
67449162069
-
Polymorphisms in XRCC1 and XPG and response to platinumbased chemotherapy in advanced non-small cell lung cancer patients
-
Sun, X.; Li, F.; Sun, N.; Shukui, Q.; Baoan, C.; Jifeng, F.; Lu, C.; Zuhong, L.; Hongyan, C.; YuanDong, C.; Jiazhong, J.; Yingfeng, Z. Polymorphisms in XRCC1 and XPG and response to platinumbased chemotherapy in advanced non-small cell lung cancer patients. Lung Cancer, 2009, 65(2), 230-236.
-
(2009)
Lung Cancer
, vol.65
, Issue.2
, pp. 230-236
-
-
Sun, X.1
Li, F.2
Sun, N.3
Shukui, Q.4
Baoan, C.5
Jifeng, F.6
Lu, C.7
Zuhong, L.8
Hongyan, C.9
Yuandong, C.10
Jiazhong, J.11
Yingfeng, Z.12
-
75
-
-
70349435434
-
ERCC1 and XRCC1 gene polymorphisms predict response to neoadjuvant radiochemotherapy in esophageal cancer
-
Warnecke-Eberz, U.; Vallbohmer, D.; Alakus, H.; Kutting, F.; Lurje, G.; Bollschweiler, E.; Wienand-Dorweiler, A.; Drebber, U.; Holscher, A. H.; Metzger, R., ERCC1 and XRCC1 gene polymorphisms predict response to neoadjuvant radiochemotherapy in esophageal cancer. J. Gastrointest. Surg., 2009, 13(8), 1411-1421.
-
(2009)
J. Gastrointest. Surg
, vol.13
, Issue.8
, pp. 1411-1421
-
-
Warnecke-Eberz, U.1
Vallbohmer, D.2
Alakus, H.3
Kutting, F.4
Lurje, G.5
Bollschweiler, E.6
Wienand-Dorweiler, A.7
Drebber, U.8
Holscher, A.H.9
Metzger, R.10
-
76
-
-
33646241783
-
Polymorphisms in genes of nucleotide and base excision repair: Risk and prognosis of colorectal cancer
-
Moreno, V.; Gemignani, F.; Landi, S.; Gioia-Patricola, L.; Chabrier, A.; Blanco, I.; Gonzalez, S.; Guino, E.; Capella, G.; Canzian, F. Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clin. Cancer Res., 2006, 12(7 Pt. 1), 2101-2108.
-
(2006)
Clin. Cancer Res
, vol.12
, Issue.7 Pt. 1
, pp. 2101-2108
-
-
Moreno, V.1
Gemignani, F.2
Landi, S.3
Gioia-Patricola, L.4
Chabrier, A.5
Blanco, I.6
Gonzalez, S.7
Guino, E.8
Capella, G.9
Canzian, F.10
-
77
-
-
34247893863
-
Combined analysis of genetic polymorphisms in thymidylate synthase, uridine diphosphate glucoronosyltransferase and X-ray cross complementing factor 1 genes as a prognostic factor in advanced colorectal cancer patients treated with 5-fluorouracil plus oxaliplatin or irinotecan
-
Martinez-Balibrea, E.; Manzano, J.L.; Martinez-Cardus, A.; Moran, T.; Cirauqui, B.; Catot, S.; Taron, M.; Abad, A. Combined analysis of genetic polymorphisms in thymidylate synthase, uridine diphosphate glucoronosyltransferase and X-ray cross complementing factor 1 genes as a prognostic factor in advanced colorectal cancer patients treated with 5-fluorouracil plus oxaliplatin or irinotecan. Oncol. Rep., 2007, 17(3), 637-645.
-
(2007)
Oncol. Rep
, vol.17
, Issue.3
, pp. 637-645
-
-
Martinez-Balibrea, E.1
Manzano, J.L.2
Martinez-Cardus, A.3
Moran, T.4
Cirauqui, B.5
Catot, S.6
Taron, M.7
Abad, A.8
-
78
-
-
3843130823
-
A multivariate analysis of genomic polymorphisms: Prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer
-
Stoehlmacher, J.; Park, D.J.; Zhang, W.; Yang, D.; Groshen, S.; Zahedy, S.; Lenz, H.J. A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer. Br. J. Cancer, 2004, 91(2), 344-354.
-
(2004)
Br. J. Cancer
, vol.91
, Issue.2
, pp. 344-354
-
-
Stoehlmacher, J.1
Park, D.J.2
Zhang, W.3
Yang, D.4
Groshen, S.5
Zahedy, S.6
Lenz, H.J.7
-
79
-
-
77954677109
-
The combination of ERCC1 and XRCC1 gene polymorphisms better predicts clinical outcome to oxaliplatin-based chemotherapy in metastatic colorectal cancer
-
Liang, J.; Jiang, T.; Yao, R.Y.; Liu, Z.M.; Lv, H. Y.; Qi, W.W. The combination of ERCC1 and XRCC1 gene polymorphisms better predicts clinical outcome to oxaliplatin-based chemotherapy in metastatic colorectal cancer. Cancer Chemother. Pharmacol., 2010, 66(3), 493-500.
-
(2010)
Cancer Chemother. Pharmacol
, vol.66
, Issue.3
, pp. 493-500
-
-
Liang, J.1
Jiang, T.2
Yao, R.Y.3
Liu, Z.M.4
Lv, H.Y.5
Qi, W.W.6
-
80
-
-
34848912861
-
Polymorphism of XRCC1 predicts overall survival of gastric cancer patients receiving oxaliplatinbased chemotherapy in Chinese population
-
Liu, B.; Wei, J.; Zou, Z.; Qian, X.; Nakamura, T.; Zhang, W.; Ding, Y.; Feng, J.; Yu, L. Polymorphism of XRCC1 predicts overall survival of gastric cancer patients receiving oxaliplatinbased chemotherapy in Chinese population. Eur. J. Hum. Genet., 2007, 15(10), 1049-1053.
-
(2007)
Eur. J. Hum. Genet
, vol.15
, Issue.10
, pp. 1049-1053
-
-
Liu, B.1
Wei, J.2
Zou, Z.3
Qian, X.4
Nakamura, T.5
Zhang, W.6
Ding, Y.7
Feng, J.8
Yu, L.9
-
81
-
-
33646347924
-
Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy
-
Ruzzo, A.; Graziano, F.; Kawakami, K.; Watanabe, G.; Santini, D.; Catalano, V.; Bisonni, R.; Canestrari, E.; Ficarelli, R.; Menichetti, E.T.; Mari, D.; Testa, E.; Silva, R.; Vincenzi, B.; Giordani, P.; Cascinu, S.; Giustini, L.; Tonini, G.; Magnani, M. Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy. J. Clin. Oncol., 2006, 24(12), 1883-1891.
-
(2006)
J. Clin. Oncol
, vol.24
, Issue.12
, pp. 1883-1891
-
-
Ruzzo, A.1
Graziano, F.2
Kawakami, K.3
Watanabe, G.4
Santini, D.5
Catalano, V.6
Bisonni, R.7
Canestrari, E.8
Ficarelli, R.9
Menichetti, E.T.10
Mari, D.11
Testa, E.12
Silva, R.13
Vincenzi, B.14
Giordani, P.15
Cascinu, S.16
Giustini, L.17
Tonini, G.18
Magnani, M.19
-
82
-
-
77953214042
-
BRCA1 and XRCC1 polymorphisms associated with survival in advanced gastric cancer treated with taxane and cisplatin
-
Shim, H.J.; Yun, J.Y.; Hwang, J.E.; Bae, W.K.; Cho, S.H.; Lee, J.H.; Kim, H.N.; Shin, M.H.; Kweon, S.S.; Lee, J.H.; Kim, H.J.; Chung, I.J. BRCA1 and XRCC1 polymorphisms associated with survival in advanced gastric cancer treated with taxane and cisplatin. Cancer Sci., 2010, 101(5), 1247-1254.
-
(2010)
Cancer Sci
, vol.101
, Issue.5
, pp. 1247-1254
-
-
Shim, H.J.1
Yun, J.Y.2
Hwang, J.E.3
Bae, W.K.4
Cho, S.H.5
Lee, J.H.6
Kim, H.N.7
Shin, M.H.8
Kweon, S.S.9
Lee, J.H.10
Kim, H.J.11
Chung, I.J.12
-
83
-
-
75149128076
-
DNA repair gene XRCC1 polymorphisms and outcome of renal cell carcinoma in Caucasian patients
-
Bachmann, H.S.; Rubben, H.; Schmid, K.W.; Siffert, W.; Riemann, K. DNA repair gene XRCC1 polymorphisms and outcome of renal cell carcinoma in Caucasian patients. Anticancer Res., 2009, 29(12), 5131-5135.
-
(2009)
Anticancer Res
, vol.29
, Issue.12
, pp. 5131-5135
-
-
Bachmann, H.S.1
Rubben, H.2
Schmid, K.W.3
Siffert, W.4
Riemann, K.5
-
84
-
-
34250213645
-
Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer
-
Jaremko, M.; Justenhoven, C.; Schroth, W.; Abraham, B.K.; Fritz, P.; Vollmert, C.; Illig, T.; Simon, W.; Schwab, M.; Brauch, H. Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer. Pharmacogenet. Genomics, 2007, 17(7), 529-538.
-
(2007)
Pharmacogenet. Genomics
, vol.17
, Issue.7
, pp. 529-538
-
-
Jaremko, M.1
Justenhoven, C.2
Schroth, W.3
Abraham, B.K.4
Fritz, P.5
Vollmert, C.6
Illig, T.7
Simon, W.8
Schwab, M.9
Brauch, H.10
-
85
-
-
34247122055
-
Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancer
-
Bewick, M.A.; Conlon, M.S.; Lafrenie, R.M. Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancer. J. Clin. Oncol., 2006, 24(36), 5645-5651.
-
(2006)
J. Clin. Oncol
, vol.24
, Issue.36
, pp. 5645-5651
-
-
Bewick, M.A.1
Conlon, M.S.2
Lafrenie, R.M.3
-
86
-
-
33748324572
-
Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy
-
Sakano, S.; Wada, T.; Matsumoto, H.; Sugiyama, S.; Inoue, R.; Eguchi, S.; Ito, H.; Ohmi, C.; Matsuyama, H.; Naito, K. Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy. Br. J. Cancer, 2006, 95(5), 561-70.
-
(2006)
Br. J. Cancer
, vol.95
, Issue.5
, pp. 561-570
-
-
Sakano, S.1
Wada, T.2
Matsumoto, H.3
Sugiyama, S.4
Inoue, R.5
Eguchi, S.6
Ito, H.7
Ohmi, C.8
Matsuyama, H.9
Naito, K.10
-
87
-
-
56149116930
-
XRCC1 codon 399 mutant allele: A risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy
-
Mittal, R.D.; Singh, R.; Manchanda, P.K.; Ahirwar, D.; Gangwar, R.; Kesarwani, P.; Mandhani, A. XRCC1 codon 399 mutant allele: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy. Cancer Biol. Ther., 2008, 7(5), 645-650.
-
(2008)
Cancer Biol. Ther
, vol.7
, Issue.5
, pp. 645-650
-
-
Mittal, R.D.1
Singh, R.2
Manchanda, P.K.3
Ahirwar, D.4
Gangwar, R.5
Kesarwani, P.6
Mandhani, A.7
-
88
-
-
71949118572
-
Association between XRCC1 polymorphisms and head and neck cancer in a Hungarian population
-
Csejtei, A.; Tibold, A.; Koltai, K.; Varga, Z.; Szanyi, I.; Gobel, G.; Prantner, I.; Steffler, D.; Feher, G.; De Blasio, A.; Ember, I.; Kiss, I. Association between XRCC1 polymorphisms and head and neck cancer in a Hungarian population. Anticancer Res., 2009, 29(10), 4169-4173.
-
(2009)
Anticancer Res
, vol.29
, Issue.10
, pp. 4169-4173
-
-
Csejtei, A.1
Tibold, A.2
Koltai, K.3
Varga, Z.4
Szanyi, I.5
Gobel, G.6
Prantner, I.7
Steffler, D.8
Feher, G.9
de Blasio, A.10
Ember, I.11
Kiss, I.12
-
89
-
-
33751425930
-
XRCC1 R399Q polymorphism is associated with response to platinum-based neoadjuvant chemotherapy in bulky cervical cancer
-
Chung, H.H.; Kim, M.K.; Kim, J.W.; Park, N.H.; Song, Y.S.; Kang, S.B.; Lee, H.P. XRCC1 R399Q polymorphism is associated with response to platinum-based neoadjuvant chemotherapy in bulky cervical cancer. Gynecol. Oncol., 2006, 103(3), 1031-1037.
-
(2006)
Gynecol. Oncol
, vol.103
, Issue.3
, pp. 1031-1037
-
-
Chung, H.H.1
Kim, M.K.2
Kim, J.W.3
Park, N.H.4
Song, Y.S.5
Kang, S.B.6
Lee, H.P.7
-
90
-
-
68249162551
-
The association of XRCC1 gene single nucleotide polymorphisms with response to neoadjuvant chemotherapy in locally advanced cervical carcinoma
-
Cheng, X.D.; Lu, W.G.; Ye, F.; Wan, X.Y.; Xie, X. The association of XRCC1 gene single nucleotide polymorphisms with response to neoadjuvant chemotherapy in locally advanced cervical carcinoma. J. Exp. Clin. Cancer Res., 2009, 28, 91.
-
(2009)
J. Exp. Clin. Cancer Res
, vol.28
, pp. 91
-
-
Cheng, X.D.1
Lu, W.G.2
Ye, F.3
Wan, X.Y.4
Xie, X.5
-
91
-
-
56449096906
-
XRCC1 Arginine194Tryptophan and GGH- 401Cytosine/Thymine polymorphisms are associated with response to platinum-based neoadjuvant chemotherapy in cervical cancer
-
Kim, K.; Kang, S.B.; Chung, H.H.; Kim, J.W.; Park, N.H.; Song, Y.S. XRCC1 Arginine194Tryptophan and GGH- 401Cytosine/Thymine polymorphisms are associated with response to platinum-based neoadjuvant chemotherapy in cervical cancer. Gynecol Oncol, 2008, 111(3), 509-515.
-
(2008)
Gynecol Oncol
, vol.111
, Issue.3
, pp. 509-515
-
-
Kim, K.1
Kang, S.B.2
Chung, H.H.3
Kim, J.W.4
Park, N.H.5
Song, Y.S.6
-
92
-
-
77953772492
-
Possible associations of APE1 polymorphism with susceptibility and HOGG1 polymorphism with prognosis in gastric cancer
-
Canbay, E.; Agachan, B.; Gulluoglu, M.; Isbir, T.; Balik, E.; Yamaner, S.; Bulut, T.; Cacina, C.; Eraltan, I.Y.; Yilmaz, A.; Bugra, D. Possible associations of APE1 polymorphism with susceptibility and HOGG1 polymorphism with prognosis in gastric cancer. Anticancer Res., 2010, 30(4), 1359-1364.
-
(2010)
Anticancer Res
, vol.30
, Issue.4
, pp. 1359-1364
-
-
Canbay, E.1
Agachan, B.2
Gulluoglu, M.3
Isbir, T.4
Balik, E.5
Yamaner, S.6
Bulut, T.7
Cacina, C.8
Eraltan, I.Y.9
Yilmaz, A.10
Bugra, D.11
-
93
-
-
77954415447
-
Genetic polymorphisms in XRCC1 associated with radiation therapy in prostate cancer
-
Gao, R.; Price, D.K.; Dahut, W.L.; Steinberg, S.M.; Reed, E.; Figg, W.D. Genetic polymorphisms in XRCC1 associated with radiation therapy in prostate cancer. Cancer Biol. Ther., 2010, 10(1), 13-18.
-
(2010)
Cancer Biol. Ther
, vol.10
, Issue.1
, pp. 13-18
-
-
Gao, R.1
Price, D.K.2
Dahut, W.L.3
Steinberg, S.M.4
Reed, E.5
Figg, W.D.6
-
94
-
-
84855860419
-
Association between XRCC1 G399A Polymorphism and Late Complications to Radiotherapy in Saudi Head and Neck Cancer Patients
-
Alsbeih, G.A.; El-Sebaie, M.M.; Al-Rajhi, N.M.; Al-Harbi, N.M.; Al-Hadyan, K.S.; Al-Buhairi, M.H.; Moftah, B.A.; Al-Shabanah, M.O.; Abu-Amero, K.K. Association between XRCC1 G399A Polymorphism and Late Complications to Radiotherapy in Saudi Head and Neck Cancer Patients. J. Egypt Natl. Canc Inst., 2008, 20(3), 302-308.
-
(2008)
J. Egypt Natl. Canc Inst
, vol.20
, Issue.3
, pp. 302-308
-
-
Alsbeih, G.A.1
El-Sebaie, M.M.2
Al-Rajhi, N.M.3
Al-Harbi, N.M.4
Al-Hadyan, K.S.5
Al-Buhairi, M.H.6
Moftah, B.A.7
Al-Shabanah, M.O.8
Abu-Amero, K.K.9
-
95
-
-
77950208798
-
Association between normal tissue complications after radiotherapy and polymorphic variations in TGFB1 and XRCC1 genes
-
Alsbeih, G.; Al-Harbi, N.; Al-Hadyan, K.; El-Sebaie, M.; Al-Rajhi, N. Association between normal tissue complications after radiotherapy and polymorphic variations in TGFB1 and XRCC1 genes. Radiat. Res., 2010, 173(4), 505-511.
-
(2010)
Radiat. Res
, vol.173
, Issue.4
, pp. 505-511
-
-
Alsbeih, G.1
Al-Harbi, N.2
Al-Hadyan, K.3
El-Sebaie, M.4
Al-Rajhi, N.5
-
96
-
-
46449108180
-
Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer
-
Burri, R.J.; Stock, R.G.; Cesaretti, J.A.; Atencio, D.P.; Peters, S.; Peters, C.A.; Fan, G.; Stone, N.N.; Ostrer, H.; Rosenstein, B.S. Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer. Radiat. Res., 2008, 170(1), 49-59.
-
(2008)
Radiat. Res
, vol.170
, Issue.1
, pp. 49-59
-
-
Burri, R.J.1
Stock, R.G.2
Cesaretti, J.A.3
Atencio, D.P.4
Peters, S.5
Peters, C.A.6
Fan, G.7
Stone, N.N.8
Ostrer, H.9
Rosenstein, B.S.10
-
97
-
-
52149093686
-
XRCC1 polymorphisms and severe toxicity in lung cancer patients treated with cisplatin-based chemotherapy in Chinese population
-
Wang, Z.; Xu, B.; Lin, D.; Tan, W.; Leaw, S.; Hong, X.; Hu, X. XRCC1 polymorphisms and severe toxicity in lung cancer patients treated with cisplatin-based chemotherapy in Chinese population. Lung Cancer, 2008, 62(1), 99-104.
-
(2008)
Lung Cancer
, vol.62
, Issue.1
, pp. 99-104
-
-
Wang, Z.1
Xu, B.2
Lin, D.3
Tan, W.4
Leaw, S.5
Hong, X.6
Hu, X.7
-
98
-
-
77957877713
-
Association of single nucleotide polymorphisms in ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with clinical and cellular radiosensitivity
-
Zschenker, O.; Raabe, A.; Boeckelmann, I.K.; Borstelmann, S.; Szymczak, S.; Wellek, S.; Rades, D.; Hoeller, U.; Ziegler, A.; Dikomey, E.; Borgmann, K. Association of single nucleotide polymorphisms in ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with clinical and cellular radiosensitivity. Radiother. Oncol., 2010, 97(1), 26-32.
-
(2010)
Radiother. Oncol
, vol.97
, Issue.1
, pp. 26-32
-
-
Zschenker, O.1
Raabe, A.2
Boeckelmann, I.K.3
Borstelmann, S.4
Szymczak, S.5
Wellek, S.6
Rades, D.7
Hoeller, U.8
Ziegler, A.9
Dikomey, E.10
Borgmann, K.11
-
99
-
-
27644497125
-
Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients
-
Chang-Claude, J.; Popanda, O.; Tan, X.L.; Kropp, S.; Helmbold, I.; von Fournier, D.; Haase, W.; Sautter-Bihl, M.L.; Wenz, F.; Schmezer, P.; Ambrosone, C.B. Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin. Cancer Res., 2005, 11(13), 4802-4809.
-
(2005)
Clin. Cancer Res
, vol.11
, Issue.13
, pp. 4802-4809
-
-
Chang-Claude, J.1
Popanda, O.2
Tan, X.L.3
Kropp, S.4
Helmbold, I.5
von Fournier, D.6
Haase, W.7
Sautter-Bihl, M.L.8
Wenz, F.9
Schmezer, P.10
Ambrosone, C.B.11
-
100
-
-
0344198151
-
Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy
-
Moullan, N.; Cox, D.G.; Angele, S.; Romestaing, P.; Gerard, J.P.; Hall, J. Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol. Biomarkers Prev., 2003, 12(11 Pt. 1), 1168-1174.
-
(2003)
Cancer Epidemiol. Biomarkers Prev
, vol.12
, Issue.11 Pt. 1
, pp. 1168-1174
-
-
Moullan, N.1
Cox, D.G.2
Angele, S.3
Romestaing, P.4
Gerard, J.P.5
Hall, J.6
-
101
-
-
0344676392
-
Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes
-
Andreassen, C.N.; Alsner, J.; Overgaard, M.; Overgaard, J., Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. Radiother Oncol., 2003, 69(2), 127-135.
-
(2003)
Radiother Oncol
, vol.69
, Issue.2
, pp. 127-135
-
-
Andreassen, C.N.1
Alsner, J.2
Overgaard, M.3
Overgaard, J.4
-
102
-
-
33748577313
-
Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATM--a study based on DNA from formalin fixed paraffin embedded tissue samples
-
Andreassen, C.N.; Alsner, J.; Overgaard, M.; Sorensen, F.B.; Overgaard, J. Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATM--a study based on DNA from formalin fixed paraffin embedded tissue samples. Int. J. Radiat. Biol., 2006, 82(8), 577-586.
-
(2006)
Int. J. Radiat. Biol
, vol.82
, Issue.8
, pp. 577-586
-
-
Andreassen, C.N.1
Alsner, J.2
Overgaard, M.3
Sorensen, F.B.4
Overgaard, J.5
-
103
-
-
18144374862
-
TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer
-
Andreassen, C.N.; Alsner, J.; Overgaard, J.; Herskind, C.; Haviland, J.; Owen, R.; Homewood, J.; Bliss, J.; Yarnold, J. TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer. Radiother. Oncol., 2005, 75(1), 18-21.
-
(2005)
Radiother. Oncol
, vol.75
, Issue.1
, pp. 18-21
-
-
Andreassen, C.N.1
Alsner, J.2
Overgaard, J.3
Herskind, C.4
Haviland, J.5
Owen, R.6
Homewood, J.7
Bliss, J.8
Yarnold, J.9
-
104
-
-
21244472962
-
Radiation-induced damage to normal tissues after radiotherapy in patients treated for gynecologic tumors: Association with single nucleotide polymorphisms in XRCC1, XRCC3, and OGG1 genes and in vitro chromosomal radiosensitivity in lymphocytes
-
De Ruyck, K.; Van Eijkeren, M.; Claes, K.; Morthier, R.; De Paepe, A.; Vral, A.; De Ridder, L.; Thierens, H. Radiation-induced damage to normal tissues after radiotherapy in patients treated for gynecologic tumors: association with single nucleotide polymorphisms in XRCC1, XRCC3, and OGG1 genes and in vitro chromosomal radiosensitivity in lymphocytes. Int. J. Radiat. Oncol. Biol. Phys., 2005, 62(4), 1140-1149.
-
(2005)
Int. J. Radiat. Oncol. Biol. Phys
, vol.62
, Issue.4
, pp. 1140-1149
-
-
de Ruyck, K.1
van Eijkeren, M.2
Claes, K.3
Morthier, R.4
de Paepe, A.5
Vral, A.6
de Ridder, L.7
Thierens, H.8
|